FDA
approval
· 2020-08-20
FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
Summary
The FDA approved a supplemental application for Tribenzor (olmesartan medoxomil/amlodipine besylate/hydrochlorothiazide) from Cosette Pharmaceuticals, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRIBENZOR (OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE)